Another example of the use of EV in therapy was demonstrated by Ohno et al. [76], who engineered cells to obtain EV expressing the GE11 peptide fused with the transmembrane domain of platelet-derived growth factor receptor and which showed an efficient in vivo delivery of miRNA to breast cancer cells bearing the epidermal growth factor receptor (EGFR). Here, EGFR is linked to breast cancer.